Chronic Site

: This follows a similar slide by 2025 prospect Will Johnson , who fell to the 47th pick over fears that chronic injuries would shorten his professional career [24].

: Organizations like SIGN are also updating their recommendations to emphasize that opioids should not be routinely prescribed for chronic pain due to insufficient evidence of long-term benefit [27, 35]. Managing Life with Chronic Pain Chronic

: In January 2025, the FDA approved Journavx (Suzetrigine) , the first non-opioid analgesic for moderate to severe acute pain, signaling a major step toward these new standards [33, 34]. : This follows a similar slide by 2025

: Experts at Dr. Vince Clinical Research note that the 2025 draft guidance introduces a flexible, mechanism-based framework. This allows drug developers to target shared pain pathways across multiple conditions rather than conducting duplicative trials for every specific ailment [2]. : Experts at Dr